Issue 23, 2023

Rigid H4OCTAPA derivatives as model chelators for the development of Bi(iii)-based radiopharmaceuticals

Abstract

Octadentate ligands containing ethyl (H4OCTAPA), cyclohexyl (H4CHXOCTAPA) or cyclopentyl (H4CpOCTAPA) spacers were assessed as chelators for Bi(III)-based radiopharmaceuticals. The H4CHXOCTAPA chelator displays excellent properties, including 205/206Bi-nuclide radiolabelling under mild conditions, excellent stability in serum and in the presence of competing cations or H5DTPA. The poor performance of H4CpOCTAPA appears to be related to the stereochemical activity of the Bi(III) lone pair.

Graphical abstract: Rigid H4OCTAPA derivatives as model chelators for the development of Bi(iii)-based radiopharmaceuticals

Supplementary files

Article information

Article type
Communication
Submitted
17 Dec 2022
Accepted
21 Feb 2023
First published
21 Feb 2023

Chem. Commun., 2023,59, 3443-3446

Rigid H4OCTAPA derivatives as model chelators for the development of Bi(III)-based radiopharmaceuticals

F. Lucio-Martínez, D. Esteban-Gómez, L. Valencia, D. Horváth, D. Szücs, A. Fekete, D. Szikra, G. Tircsó and C. Platas-Iglesias, Chem. Commun., 2023, 59, 3443 DOI: 10.1039/D2CC06876A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements